COVID-19 Coagulopathy Extension Study
COVID-19 Coagulopathy Extension Study
Recruiting · NCT05334615 · Registry updated 2025-04-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| COVID-19 Coagulopathy Extension Study | COVID-19, Coronaviridae Infections, Embolism and Thrombosis, Hemic and Lymphatic Diseases, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, cardiovascular disorder, hematologic disorder, hemorrhagic disease, influenza, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, thrombotic disease, vascular disorder, vascular hemostatic disease, viral infectious disease, viral pneumonia | Recruiting | Not stated | 2025-04-06 | NCT05334615 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 402 |
| University of Iowa | 102 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Iowa Health Care | Iowa City | United States | 47 |